Malaysia has steadily been working to establish itself in the global biotech industry through government and private enterprise efforts. The future heart of the Malaysian biotech industry will be BioValley, a biotech zone south of Kuala Lumpur. To date, the government has invested $26 million in BioValley and it is expected to be operational by […]
Laboratory Corporation purchased laboratory automation provider Protedyne. TTP LabTech appointed Matthew Cook as commercial development manager to further develop its custom automation business. CyBio AG established a Japanese subsidiary in April. In July, CyBio AG and MACHEREY-NAGEL GmbH announced they will jointly develop applications to automate MACHEREY-NAGEL’s kits on CyBio systems. CyBio AG reported first-half […]
Thermo Fisher Scientific launched the XL3 800 Series Alloy Analyzers, the third generation of NITON handheld XRF analyzers. Thermo Fisher Scientific introduced a new kit for the coupling of GC to its ICP-MS ELEMENT 2 and ELEMENT XR for elemental speciation analysis of volatile compounds. Thermo Fisher Scientific released an entry-level version of its ARL […]
Chris van Ingen, president of Agilent’s Bio-Analytical Measurement unit, which is also known as Chemical Analysis and Life Sciences (LSCA), has spent close to 30 years working in the analytical instrument industry. On the occasion of the announcement of his retirement from Agilent at the end of Agilent’s fiscal year on October 31 (see IBO […]
Founded in 2001, the Canadian firm GenoLogics is based in Victoria, British Columbia, and develops laboratory information management systems (LIMS). The company’s first product was a LIMS for proteomics that grew out of a collaboration with the University of Victoria Genome BC Proteomics Center. As Tanis McSween, manager of marketing communications, explained, these collaborations gave […]
Stem cells have the ability to develop into almost any kind of cell. Spurred by stem cells’ potential to replace diseased cells and cure a wide variety of diseases, scientists around the globe have been studying the qualities of these cells. Because many different properties of stem cells still need to be understood, there are […]
On September 10, the US government’s Interagency Working Group on Import Safety issued its first report on import safety. The Group, which includes personnel from 12 federal departments and agencies, was created in July by the Bush Administration following the discovery of tainted imported pet food (see IBO 5/31/07). The report recommends a strategic framework […]
In August, the US Patent and Trademark Office (USPTO) announced new rules for the patenting process, which will take effect on November 1. Under the new rules, patent submissions can not include more than 25 claims, and inventors will only be able to file two new “continuing applications,” which allow inventors to add further claims […]
In June, Agilent appointed Neil Cook, PhD, as vice president and director of the Molecular Technology Laboratory at Agilent Laboratories. He will also serve as the R&D/technology manager for the Life Sciences and Chemical Analysis business. Most recently, he was vice president for research and business development and chief scientific officer for PerkinElmer Life and […]
In July, Thermo Fisher Scientific announced the production of its 500th iCAP 6000 ICP emission spectrometer at its facility in Cambridge, UK. The product was shipped to Boeing.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
